Psoralen

Psoralen has been studied in 4 papers since 2026: none in people yet, 2 in animals, 2 reviews; 4 in the past year. The research so far is in animals.

InterventionPhase 2

4 papers study it2 more mention it4 findingsUpdated

PubChemChEBI

1 new paper in 30 daysSee all 4 papers on psoralen

At a glance

The findings reach mice, none yet in people. 2 independent labs in 1 country; 2 trials, none about aging, 1 with no results posted.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 2 independent labs in 1 country
  • 2 trials, none about aging, 1 with no results posted
  • Funder: National Natural Science Foundation of China
  • Animals2

What did studies of psoralen find?

4

Studies of psoralen measured 4 outcomes, among them Osteoblast proliferation, APP phosphorylation and bone degenerative lesions.

Osteoblast proliferation

upin mouse cells1

1 study
  1. Psoralen increases osteoblast proliferation in mouse cells.

    “intervention with psoralen in osteoblasts promoted osteoblast proliferation”

    Cellsosteoblast

    Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation to regulate MAPK and STAT3 signaling

    American journal of translational research

APP phosphorylation

downin mice1

1 study
  1. Psoralen inhibits APP phosphorylation in mice.

    “Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation”

    Animals

    Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation to regulate MAPK and STAT3 signaling

    American journal of translational research

Bone degenerative lesions

downin mice1

1 study
  1. Psoralen decreases bone degenerative lesions in mice.

    “Intervention with psoralen was effective for ameliorating the pathologic condition of bone degenerative lesions in mice”

    Animalsin three degenerative models (knee osteoarthritis, osteoporosis, intervertebral disc degeneration)bone

    Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation to regulate MAPK and STAT3 signaling

    American journal of translational research

cAMP signaling

upin mouse cells1

1 study
  1. Psoralen activates cAMP signaling in MEFs.

    “Psr co-treatment potently activated the ADCY9/cAMP/PKA/CREB pathway”

    Cellsin MEFs

    Psoralen Promotes Direct Chemical Reprogramming of Mouse Embryonic Fibroblasts into Osteoblast-like Cells

    Pharmaceutics

More on cAMP signaling

Has psoralen been tested in people?

0 of 2 about aging

2 trials are registered, but no study of it in people has been published yet.

In trials

All 12

Stopped

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 03 papers in 12 months